Ustekinumab and anti-TNF agents are equally safe and effective in elderly Crohn's disease patients: A propensity adjusted multi-centre cohort study

被引：0
|
作者：
Gebeyehu, G. G. [1 ]
Broglio, G. [2 ]
Liu, E. [3 ]
Limdi, J. K. [4 ]
Selinger, C. [5 ]
Fiske, J. [1 ]
Razsanskaite, V. [1 ]
Smith, P. J. [1 ]
Flanagan, P. K. [6 ]
Subramanian, S. [7 ]
机构：
[1] Liverpool Univ Hosp NHS Fdn Trust, Dept Gastroenterol, Liverpool, Merseyside, England
[2] Univ Pavia, Dept Internal Med, IRCCS San Matteo Pavia, Pavia, Italy
[3] Northern Care Alliance NHS Trust, Sect IBD, Div Gastroenterol, Manchester, Lancs, England
[4] Univ Manchester, Manchester Acad Hlth Sci, Fac Med, Manchester, Lancs, England
[5] Leeds Univ Teaching Hosp NHS Trust, Dept Gastroenterol, Leeds, W Yorkshire, England
[6] Wirral Univ Teaching Hosp NHS Trust, Dept Gastroenterol, Wirral, Merseyside, England
[7] Cambridge Univ Hosp NHS Fdn Trust, Dept Gastroenterol, Cambridge, England
来源：
JOURNAL OF CROHNS & COLITIS | 2023年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P596
引用
收藏
页码：723 / 724
页数：2
相关论文
共 50 条
  • [1] Ustekinumab and anti-TNF agents are equally safe and effective in elderly crohn's disease patients: A propensity adjusted multi-centre cohort study
    Gebeyehu, Gerum Gashaw
    Broglio, Giacomo
    Liu, Eleanor
    Limdi, Jimmy K.
    Selinger, Christian
    Fiske, Joseph
    Razsanskaite, Violeta
    Smith, Philip J.
    Flanagan, Paul K.
    Subramanian, Sreedhar
    [J]. GUT, 2023, 72 (SUPPL_2) : A73 - A74
  • [2] COMPARATIVE EFFECTIVENESS OF VEDOLIZUMAB AND USTEKINUMAB IN ANTI-TNF REFRACTORY CROHN'S DISEASE: MULTI-CENTRE RETROSPECTIVE COHORT STUDY
    Townsend, Tristan
    Razanskaite, Violeta
    Michail, Stephanie
    Morgan, James
    Davies, Michael
    Storey, Daniel
    Watters, Christopher
    Penman, Douglas
    Swaminathan, Mira
    Reilly, Ian
    Flanagan, Paul
    Subramanian, Sreedhar
    [J]. GUT, 2021, 70 : A127 - A127
  • [3] Ustekinumab and Vedolizumab Are Equally Safe and Effective in Elderly Crohn’s Disease Patients
    Gerum Gashaw Gebeyehu
    Joseph Fiske
    Eleanor Liu
    Jimmy K. Limdi
    Giacomo Broglio
    Christian Selinger
    Violeta Razsanskaite
    Philip J. Smith
    Paul K. Flanagan
    Sreedhar Subramanian
    [J]. Digestive Diseases and Sciences, 2023, 68 : 1983 - 1994
  • [4] Ustekinumab and Vedolizumab Are Equally Safe and Effective in Elderly Crohn's Disease Patients
    Gebeyehu, Gerum Gashaw
    Fiske, Joseph
    Liu, Eleanor
    Limdi, Jimmy K.
    Broglio, Giacomo
    Selinger, Christian
    Razsanskaite, Violeta
    Smith, Philip J.
    Flanagan, Paul K.
    Subramanian, Sreedhar
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2023, 68 (05) : 1983 - 1994
  • [5] Comparative effectiveness of vedolizumab and ustekinumab as induction therapy in anti-TNF refractory Crohn's disease: a multi-centre retrospective cohort study
    Townsend, T.
    Razanskaite, V.
    Michail, S.
    Morgan, J.
    Davies, M.
    Storey, D.
    Watters, C.
    Penman, D.
    Swaminathan, M.
    Sabine, J.
    Chapman, A.
    Vyas, A.
    Reilly, I.
    Flanagan, P.
    Bodger, K.
    Subramanian, S.
    [J]. JOURNAL OF CROHNS & COLITIS, 2019, 13 : S407 - S408
  • [6] MULTI-CENTRE COMPARATIVE EFFECTIVENESS OF VEDOLIZUMAB AND USTEKINUMAB AS INDUCTION THERAPY IN ANTI-TNF REFRACTORY CROHN'S DISEASE
    Razanskaite, Violeta
    Michail, Stephanie
    Morgan, James
    Davies, Michael
    Storey, Daneil
    Watters, Christopher
    Penman, Douglas
    Swaminathan, Mira
    Sabine, Joseph
    Chapman, Adam
    Reilly, Ian
    Flanagan, Paul
    Bodger, Keith
    Subramanian, Sreedhar
    [J]. GUT, 2019, 68 : A100 - A100
  • [7] Strategy of selecting anti-TNF agent in patients with Crohn's disease: A multi-centre retrospective cohort study by the Osaka gut forum
    Amano, T.
    Shinzaki, S.
    Tashiro, T.
    Otake, Y.
    Tani, M.
    Yoshihara, T.
    Iwatani, S.
    Tsujii, Y.
    Inoue, T.
    Hayashi, Y.
    Iijima, H.
    Takehara, T.
    [J]. JOURNAL OF CROHNS & COLITIS, 2020, 14 : S551 - S551
  • [8] Comparative Safety and Effectiveness of Ustekinumab and Anti-TNF in Elderly Crohn's Disease Patients
    Gebeyehu, Gerum Gashaw
    Broglio, Giacomo
    Liu, Eleanor
    Limdi, Jimmy K.
    Selinger, Christian
    Fiske, Joseph
    Razanskaite, Violeta
    Smith, Philip J.
    Flanagan, Paul K.
    Subramanian, Sreedhar
    [J]. INFLAMMATORY BOWEL DISEASES, 2024,
  • [9] Ustekinumab is effective and safe in the treatment of Crohn's disease refractory to anti-TNFα in an orthotopic liver transplant patient
    Martinez-Montiel, M.
    Piedracoba-Cadahia, Pilar
    Gomez-Gomez, Carlos
    Gonzalo, J.
    [J]. JOURNAL OF CROHNS & COLITIS, 2015, 9 (09): : 816 - 817
  • [10] Ustekinumab Is Safe, but Less Effective in Elderly Crohn's Disease Patients
    Garg, Rajat
    Aggarwal, Manik
    Achkar, Jean P.
    Lashner, Bret
    Philpott, Jessica
    Cohen, Benjamin
    Rieder, Florian
    Qazi, Taha
    Regueiro, Miguel
    Click, Benjamin H.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S398 - S399
12345